Literature DB >> 16844729

Innate immune activation in neutrophilic asthma and bronchiectasis.

Jodie L Simpson1, Terry V Grissell, Jeroen Douwes, Rodney J Scott, Michael J Boyle, Peter G Gibson.   

Abstract

BACKGROUND: The role of the innate immune system in the pathogenesis of asthma is unclear. Activation of innate immune receptors in response to bacterial lipopolysaccharide, viral infection and particulate matter triggers a pre-programmed inflammatory response, which involves interleukin (IL)8 and neutrophil influx. The inflammatory response in asthma is heterogeneous. AIM: To test the hypothesis that innate immune activation may be a relevant inflammatory mechanism in neutrophilic asthma where IL8 levels are increased.
METHODS: Induced sputum was obtained from non-smoking adults with asthma (n = 49), healthy controls (n = 13) and a positive reference group with bronchiectasis (n = 9). Subjects with asthma were classified into inflammatory subtypes using induced sputum cell counts. Sputum was examined for mRNA expression of the innate immune receptors toll-like receptor (TLR)2, TLR4 and CD14, and inflammatory cytokines. A separate sputum portion was dispersed and the supernatant assayed for surfactant protein A, IL8, soluble CD14 and endotoxin.
RESULTS: Expression of innate immune receptors was increased in subjects with bronchiectasis and neutrophilic asthma compared with other asthma subtypes and controls. Increased expression of the receptors TLR2, TLR4 and CD14, as well as the pro-inflammatory cytokines IL8 and IL1beta, was observed. Subjects with neutrophilic asthma had higher airway levels of endotoxin than the other groups studied.
CONCLUSION: There is evidence of activation of the innate immune system in asthma which results in the production of pro-inflammatory cytokines and may contribute to the pathogenesis of neutrophilic asthma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844729      PMCID: PMC2117164          DOI: 10.1136/thx.2006.061358

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  44 in total

1.  Non-eosinophilic corticosteroid unresponsive asthma.

Authors:  I D Pavord; C E Brightling; G Woltmann; A J Wardlaw
Journal:  Lancet       Date:  1999-06-26       Impact factor: 79.321

2.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.

Authors:  S E Wenzel; L B Schwartz; E L Langmack; J L Halliday; J B Trudeau; R L Gibbs; H W Chu
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

Review 3.  Endotoxin-stimulated innate immunity: A contributing factor for asthma.

Authors:  C E Reed; D K Milton
Journal:  J Allergy Clin Immunol       Date:  2001-08       Impact factor: 10.793

4.  Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis.

Authors:  J A Hubacek; F Stüber; D Fröhlich; M Book; S Wetegrove; M Ritter; G Rothe; G Schmitz
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

5.  Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma.

Authors:  Jodie L Simpson; Rodney J Scott; Michael J Boyle; Peter G Gibson
Journal:  Am J Respir Crit Care Med       Date:  2005-05-18       Impact factor: 21.405

6.  Inflammatory subtypes in asthma: assessment and identification using induced sputum.

Authors:  Jodie L Simpson; Rodney Scott; Michael J Boyle; Peter G Gibson
Journal:  Respirology       Date:  2006-01       Impact factor: 6.424

7.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements.

Authors:  E Pizzichini; M M Pizzichini; A Efthimiadis; S Evans; M M Morris; D Squillace; G J Gleich; J Dolovich; F E Hargreave
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

8.  The interrelationship of sputum inflammatory markers in patients with chronic bronchitis.

Authors:  A T Hill; D Bayley; R A Stockley
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

Review 9.  Asthma, airway inflammation and treatment in elite athletes.

Authors:  Ilkka Helenius; Aki Lumme; Tari Haahtela
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

10.  Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

Authors:  P G Gibson; J L Simpson; N Saltos
Journal:  Chest       Date:  2001-05       Impact factor: 9.410

View more
  93 in total

Review 1.  Emerging roles of T helper subsets in the pathogenesis of asthma.

Authors:  Douglas M Durrant; Dennis W Metzger
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

2.  Non-eosinophilic asthma and the innate immune response.

Authors:  Ian D Pavord
Journal:  Thorax       Date:  2007-03       Impact factor: 9.139

3.  What do non-eosinophilic asthma and airway remodelling tell us about persistent asthma?

Authors:  Peter G Gibson
Journal:  Thorax       Date:  2007-12       Impact factor: 9.139

Review 4.  The Regulatory Function of Eosinophils.

Authors:  Ting Wen; Marc E Rothenberg
Journal:  Microbiol Spectr       Date:  2016-10

Review 5.  Pathophysiology and Genetics of Bronchiectasis Unrelated to Cystic Fibrosis.

Authors:  Aleksandra Nikolic
Journal:  Lung       Date:  2018-05-12       Impact factor: 2.584

6.  ATP-binding cassette transporter 1 attenuates ovalbumin-induced neutrophilic airway inflammation.

Authors:  Cuilian Dai; Xianglan Yao; Boris Vaisman; Todd Brenner; Katharine S Meyer; Meixia Gao; Karen J Keeran; Gayle Z Nugent; Xuan Qu; Zu-Xi Yu; Pradeep K Dagur; J Philip McCoy; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

7.  Neutrophil cytoplasts induce TH17 differentiation and skew inflammation toward neutrophilia in severe asthma.

Authors:  Nandini Krishnamoorthy; David N Douda; Thayse R Brüggemann; Isabell Ricklefs; Melody G Duvall; Raja-Elie E Abdulnour; Kimberly Martinod; Luciana Tavares; Xiao Wang; Manuela Cernadas; Elliot Israel; David T Mauger; Eugene R Bleecker; Mario Castro; Serpil C Erzurum; Benjamin M Gaston; Nizar N Jarjour; Sally Wenzel; Eleanor Dunican; John V Fahy; Daniel Irimia; Denisa D Wagner; Bruce D Levy
Journal:  Sci Immunol       Date:  2018-08-03

8.  Modulation of expression in BEAS-2B airway epithelial cells of α-L-fucosidase A1 and A2 by Th1 and Th2 cytokines, and overexpression of α-L-fucosidase 2.

Authors:  Anna D Sobkowicz; Mary E Gallagher; Colm J Reid; Daniel Crean; Stephen D Carrington; Jane A Irwin
Journal:  Mol Cell Biochem       Date:  2014-01-28       Impact factor: 3.396

9.  Airway wall expression of OX40/OX40L and interleukin-4 in asthma.

Authors:  Salman Siddiqui; Vijay Mistry; Camille Doe; Sally Stinson; Martyn Foster; Christopher Brightling
Journal:  Chest       Date:  2010-02-05       Impact factor: 9.410

10.  Airways disease: phenotyping heterogeneity using measures of airway inflammation.

Authors:  Salman Siddiqui; Christopher E Brightling
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.